Cat.#: ACPP-1415
| Despition | GNAQ Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1798 | Human LMX1B Protein (AC1798) | 5 µg | inquiry |
| ACPP-1731 | Human DNAJC19 Protein (AC1731) | 2 µg | inquiry |
| ACPP-1122 | Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) | 50 µg | inquiry |
| ACPP-1067 | Recombinant Human CD11b Protein (Fc Tag) (AC1067) | 50 µg | inquiry |
| ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg | inquiry |
| ACPP-1483 | Human ENO2 Protein (AC1483) | 5 µg | inquiry |
| ACPP-1558 | Human ALK/P80 Protein (AC1558) | 2 µg | inquiry |
| ACPP-1060 | Recombinant Human ADAM17 Protein (Fc Tag) (AC1060) | 50 µg | inquiry |
| ACPP-1163 | Recombinant Human GFAP Protein (Fc Tag) (AC1163) | 50 µg | inquiry |
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.